← Leaderboards
Calum A. Macrae
Massachusetts General Hospital
$21,291,852
Attributed
$31,763,412
Total exposure
21
Grants
18
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.2M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$61,425,652 · 24
By mechanism
U54$39,889,679 · 10
R24$8,967,851 · 2
R01$6,409,679 · 4
R21$3,131,929 · 3
U01$2,078,990 · 2
R42$423,313 · 1
Top collaborators
- Raymond J Peterson16 shared
- Wolfram Goessling11 shared
- Leonard I Zon11 shared
- Randall T Peterson6 shared
- Samuel Jeffrey Aronson4 shared
- Shawn N Murphy4 shared
- Heidi L Rehm4 shared
- Lu Chen1 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Randall T Peterson$17,953,472
- Fumito Ichinose$9,083,343
Others in their field
Top investigators on “Zebrafish”
- Leonard I Zon · Children'S Hospital Boston$58,820,730
- Monte Westerfield · University Of Oregon$50,217,878
- Richard A Gibbs · Baylor College Of Medicine$49,965,365
- Karl Alexander Deisseroth · Stanford University$29,745,200
- William S Talbot · Stanford University$29,496,829
- Robert L Tanguay · Oregon State University$27,361,484
Research focus
ZebrafishCyanidesIn VivoDesignPharmaceutical PreparationsProgramsInsightBasePhenotypeToxic EffectResearch PersonnelAntidotesAnimal ModelTechnologyLeadOryctolagus CuniculusPathway InteractionsDoseResponseCommunitiesEvaluationBiologyMeetingsStructure-Activity Relationship
Grant awards (80)
A community resource for germline and somatic genetic disease modeling in zebrafish$876,458
R24 · FY2025 · OD · contact PI
AI-driven in vivo profiling in zebrafish: a platform for alcohol use disorder therapeutic discovery$423,313
R42 · FY2025 · AA
A community resource for germline and somatic genetic disease modeling in zebrafish$876,458
R24 · FY2024 · OD · contact PI
17th Annual Counteract Network Symposium$141,000
R13 · FY2024 · NS · contact PI
Advancing Novel Cyanide Countermeasures$3,104,744
U54 · FY2023 · NS · contact PI
A community resource for germline and somatic genetic disease modeling in zebrafish$896,208
R24 · FY2023 · OD · contact PI
Administrative Core for Center Management and Operations$388,094
U54 · FY2023 · NS · contact PI
Optimizing hexacholorplatinate for clinical deployment$388,093
U54 · FY2023 · NS · contact PI
Animal Modeling, Photonics, and Antidote Efficacy Core$388,092
U54 · FY2023 · NS · contact PI
Advancing Novel Cyanide Countermeasures$3,193,764
U54 · FY2022 · NS · contact PI
Animal Modeling, Photonics, and Antidote Efficacy Core$1,223,754
U54 · FY2022 · NS · contact PI
Optimizing hexacholorplatinate for clinical deployment$877,179
U54 · FY2022 · NS · contact PI
Administrative Core for Center Management and Operations$203,477
U54 · FY2022 · NS · contact PI
Advancing novel cyanide countermeasures$3,197,049
U54 · FY2021 · NS · contact PI
Animal Modeling, Photonics, and Antidote Efficacy Core$828,275
U54 · FY2021 · NS · contact PI
A Community Zebrafish Resource for Modeling GWAS Biology$770,889
R24 · FY2021 · OD
Machine learning for the automated identification and tracking of rare myocardial diseases$646,449
R01 · FY2021 · HL · contact PI
Optimizing hexacholorplatinate for clinical deployment$616,193
U54 · FY2021 · NS · contact PI
Administrative Core for Center Management and Operations$145,975
U54 · FY2021 · NS · contact PI
Advancing novel cyanide countermeasures$3,209,373
U54 · FY2020 · NS · contact PI
Animal Modeling, Photonics, and Antidote Efficacy Core$804,483
U54 · FY2020 · NS · contact PI
A Community Zebrafish Resource for Modeling GWAS Biology$770,889
R24 · FY2020 · OD
Optimizing hexacholorplatinate for clinical deployment$598,077
U54 · FY2020 · NS · contact PI
Administrative Core for Center Management and Operations$139,210
U54 · FY2020 · NS · contact PI
Advancing novel cyanide countermeasures$3,249,958
U54 · FY2019 · NS · contact PI
A Community Zebrafish Resource for Modeling GWAS Biology$770,889
R24 · FY2019 · OD
Developing i2b2 into a Health Innovation Platform for Clinical Decision Support in the Genomics Era$681,619
R01 · FY2019 · HG
Optimizing hexacholorplatinate for clinical deployment$635,200
U54 · FY2019 · NS · contact PI
Animal Modeling, Photonics, and Antidote Efficacy Core$553,939
U54 · FY2019 · NS · contact PI
Administrative Core for Center Management and Operations$162,792
U54 · FY2019 · NS · contact PI
Developing i2b2 into a Health Innovation Platform for Clinical Decision Support in the Genomics Era$881,893
R01 · FY2018 · HG
A Community Zebrafish Resource for Modeling GWAS Biology$771,156
R24 · FY2018 · OD
A Community Zebrafish Resource for Modeling GWAS Biology$751,471
R24 · FY2017 · OD · contact PI
Developing i2b2 into a Health Innovation Platform for Clinical Decision Support in the Genomics Era$683,908
R01 · FY2017 · HG
A Discovery and Development Pipeline for Cyanide Countermeasures$2,398,236
U54 · FY2016 · NS · contact PI
A Community Zebrafish Resource for Modeling GWAS Biology$822,405
R24 · FY2016 · OD · contact PI
Developing i2b2 into a Health Innovation Platform for Clinical Decision Support in the Genomics Era$696,939
R01 · FY2016 · HG
Administrative core for center management and operations$382,073
U54 · FY2016 · NS · contact PI
High throughput in vivo discovery of cyanide antidotes$227,221
U54 · FY2016 · NS · contact PI
A Discovery and Development Pipeline for Cyanide Countermeasures$150,000
U54 · FY2016 · NS · contact PI
A Discovery and Development Pipeline for Cyanide Countermeasures$2,443,895
U54 · FY2015 · NS · contact PI
A Community Zebrafish Resource for Modeling GWAS Biology$810,727
R24 · FY2015 · OD · contact PI
Administrative core for center management and operations$379,653
U54 · FY2015 · NS · contact PI
High throughput in vivo discovery of cyanide antidotes$227,288
U54 · FY2015 · NS · contact PI
A Discovery and Development Pipeline for Cyanide Countermeasures$2,396,827
U54 · FY2014 · NS · contact PI
A Community Zebrafish Resource for Modeling GWAS Biology$850,301
R24 · FY2014 · OD · contact PI
Development of a High-throughput Integrated In Vivo Heart Failure Assay$431,548
R01 · FY2014 · HL · contact PI
Administrative core for center management and operations$382,025
U54 · FY2014 · NS · contact PI
High throughput in vivo discovery of cyanide antidotes$227,222
U54 · FY2014 · NS · contact PI
A Discovery and Development Pipeline for Cyanide Countermeasures$2,526,499
U54 · FY2013 · NS · contact PI
Administrative core for center management and operations$454,320
U54 · FY2013 · NS · contact PI
Development of a High-throughput Integrated In Vivo Heart Failure Assay$407,956
R01 · FY2013 · HL · contact PI
High throughput in vivo discovery of cyanide antidotes$291,254
U54 · FY2013 · NS · contact PI
The Genetic Basis of the GAPO Progeroid Syndrome$210,853
R21 · FY2013 · AG · contact PI
A Discovery and Development Pipeline for Cyanide Countermeasures$2,707,817
U54 · FY2012 · NS · contact PI
Administrative core for center management and operations$623,051
U54 · FY2012 · NS · contact PI
Development of a High-throughput Integrated In Vivo Heart Failure Assay$454,425
R01 · FY2012 · HL · contact PI
The Genetic Basis of the GAPO Progeroid Syndrome$267,750
R21 · FY2012 · AG · contact PI
High throughput in vivo discovery of cyanide antidotes$164,577
U54 · FY2012 · NS · contact PI
Unbiased screens in zebrafish for new classes of cyanide countermeasure$89,166
U01 · FY2011 · NS · contact PI
Functional evaluation of GWAS loci for cardiovascular intermediate phenotypes$513,029
R21 · FY2010 · HL · contact PI
Unbiased screens in zebrafish for new classes of cyanide countermeasure$342,437
U01 · FY2010 · NS · contact PI
Functional evaluation of GWAS loci for cardiovascular intermediate phenotypes$544,391
R21 · FY2009 · HL · contact PI
Unbiased screens in zebrafish for new classes of cyanide countermeasure$342,437
U01 · FY2009 · NS · contact PI
Unbiased screens in zebrafish for new classes of cyanide countermeasure$332,333
U01 · FY2009 · NS · contact PI
Unbiased screens in zebrafish for new classes of cyanide countermeasure$251,808
U01 · FY2009 · NS · contact PI
Unbiased screens in zebrafish for new classes of cyanide countermeasure$80,525
U01 · FY2009 · NS · contact PI
Zebrafish Assays Predictive for Cardiotoxicity(RMI)$385,088
R21 · FY2008 · GM · contact PI
The Genetic Basis of Lone Atrial Fibrillation$373,347
R01 · FY2008 · HL · contact PI
Unbiased screens in zebrafish for new classes of cyanide countermeasure$320,142
U01 · FY2008 · NS · contact PI
Unbiased screens in zebrafish for new classes of cyanide countermeasure$320,142
U01 · FY2008 · NS · contact PI
Zebrafish Assays Predictive for Cardiotoxicity(RMI)$392,547
R21 · FY2007 · GM · contact PI
The Genetic Basis of Lone Atrial Fibrillation$373,347
R01 · FY2007 · HL · contact PI
Zebrafish Assays Predictive for Cardiotoxicity$404,271
R21 · FY2006 · GM · contact PI
The Genetic Basis of Lone Atrial Fibrillation$384,498
R01 · FY2006 · HL · contact PI
Zebrafish Assays Predictive for Cardiotoxicity(RMI)$414,000
R21 · FY2005 · GM
The Genetic Basis of Lone Atrial Fibrillation$393,750
R01 · FY2005 · HL
Genetic Studies of Cardiac Pacemaking in the Zebrafish$127,737
K08 · FY2004 · HL
Genetic Studies of Cardiac Pacemaking in the Zebrafish$127,737
K08 · FY2003 · HL
Genetic Studies of Cardiac Pacemaking in the Zebrafish$127,737
K08 · FY2002 · HL